Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 26

India’s Generic Medicine Supply Chain: NITI Aayog Warns of Critical Chinese API Dependence

  • Post published:June 24, 2026
  • Post category:Knowledge

India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…

Continue Reading India’s Generic Medicine Supply Chain: NITI Aayog Warns of Critical Chinese API Dependence

India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform

  • Post published:June 22, 2026
  • Post category:Knowledge

June 2026 marks a pivotal moment for India's generic pharmaceutical industry. From landmark shifts toward women's health therapeutics to explosive growth in the generic GLP-1 market and sweeping drug-quality reforms,…

Continue Reading India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform

Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

  • Post published:June 22, 2026
  • Post category:Knowledge

One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…

Continue Reading Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

  • Post published:June 21, 2026
  • Post category:News

Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…

Continue Reading Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars
  • Go to the previous page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 31
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve